{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03187951", "pid": "30", "mcid": "134", "text": "scheduled to receive preoperative therapy (chemotherapy, radiation or chemoradiation) either on- or off-protocol.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03128008", "pid": "30", "mcid": "2720", "text": "no prior chemotherapy or radiotherapy for nsclc", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT03096418", "pid": "30", "mcid": "4363", "text": "patients must be candidates for neoadjuvant paclitaxel chemotherapy by their treating oncologist. no other investigational or commercial therapeutic agents may be given concurrently with the paclitaxel.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02995330", "pid": "30", "mcid": "9284", "text": "prior chemotherapy (docetaxel, cabazitaxel) for castrate resistant prostate cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02926729", "pid": "30", "mcid": "11845", "text": "any systemic neoadjuvant (or preoperative) therapy between the core biopsy and lumpectomy.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02843568", "pid": "30", "mcid": "14589", "text": "prior thoracic radiotherapy", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02772562", "pid": "30", "mcid": "16431", "text": "neoadjuvant or adjuvant therapy of any kind", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02743494", "pid": "30", "mcid": "17365", "text": "did not receive concurrent chemoradiotherapy prior to surgery", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02719847", "pid": "30", "mcid": "17977", "text": "patient has received prior chemotherapy or radiotherapy for this cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02678351", "pid": "30", "mcid": "18983", "text": "androgen deprivation therapy or other neoadjuvant treatments prior to pet imaging and surgery", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01570998", "pid": "30", "mcid": "50354", "text": "patients undergoing primary systemic treatment (hormones or chemotherapy) as initial treatment with neoadjuvant reducing tumor size", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02603757", "pid": "30", "mcid": "20774", "text": "diagnosed with stage iii colon or stage ii/iii rectal cancer that will receive neoadjuvant or adjuvant chemotherapy but have not yet started", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02584244", "pid": "30", "mcid": "21729", "text": "subjects may have previously received pre-operative radiation therapy and neoadjuvant chemotherapy.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02578641", "pid": "30", "mcid": "22144", "text": "adjuvant immunotherapy/ biologics prior adjuvant immunotherapy/ biologics must be > 6 months before screening", "entities": [{"id": 551, "label": "TVariable", "start_offset": 34, "end_offset": 62}, {"id": 552, "label": "TCreGt", "start_offset": 34, "end_offset": 39}, {"id": 553, "label": "TValue", "start_offset": 84, "end_offset": 85}, {"id": 554, "label": "TUnit", "start_offset": 86, "end_offset": 92}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02522715", "pid": "30", "mcid": "25057", "text": "chemotherapy given neoadjuvantly, adjuvantly or for hormone sensitive metastatic disease is permitted as long as the cancer did not progress on chemotherapy and > 6 months have elapsed", "entities": [{"id": 555, "label": "TVariable", "start_offset": 34, "end_offset": 156}, {"id": 556, "label": "TCreGt", "start_offset": 161, "end_offset": 162}, {"id": 557, "label": "TValue", "start_offset": 163, "end_offset": 164}, {"id": 558, "label": "TUnit", "start_offset": 165, "end_offset": 171}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01532687", "pid": "30", "mcid": "50754", "text": "neoadjuvant or adjuvant therapy will not count towards prior treatment for metastatic disease, unless the patient relapsed within 2 years of completing such therapy.", "entities": [{"id": 559, "label": "TVariable", "start_offset": -1, "end_offset": 12}, {"id": 560, "label": "TCreLt", "start_offset": 123, "end_offset": 129}, {"id": 561, "label": "TValue", "start_offset": 130, "end_offset": 131}, {"id": 562, "label": "TUnit", "start_offset": 132, "end_offset": 137}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02456857", "pid": "30", "mcid": "29108", "text": "at least 1.0 cm of measurable residual disease after neoadjuvant anthracycline-based chemotherapy", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02427581", "pid": "30", "mcid": "30364", "text": "received chemotherapy, radiotherapy or biologic therapy within the last 30 days (neoadjuvant chemotherapy excluded).", "entities": [{"id": 563, "label": "TVariable", "start_offset": 23, "end_offset": 55}, {"id": 564, "label": "TCreLt", "start_offset": 56, "end_offset": 62}, {"id": 565, "label": "TValue", "start_offset": 72, "end_offset": 74}, {"id": 566, "label": "TUnit", "start_offset": -1, "end_offset": 8}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02394535", "pid": "30", "mcid": "31931", "text": "prior abdominal radiotherapy", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02349867", "pid": "30", "mcid": "33687", "text": "prior radiotherapy for pancreatic cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02328313", "pid": "30", "mcid": "34744", "text": "scheduled to begin an appropriate adjuvant or neoadjuvant chemotherapy regimen as defined by nccn guidelines (www.nccn.org)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02324387", "pid": "30", "mcid": "34855", "text": "has biopsy-proven invasive breast cancer (bi-rads 6) and scheduled for neoadjuvant chemotherapy (nac).", "entities": [{"id": 567, "label": "TVariable", "start_offset": 4, "end_offset": 40}, {"id": 568, "label": "", "start_offset": -1, "end_offset": -1}, {"id": 569, "label": "TValue", "start_offset": 50, "end_offset": 51}, {"id": 570, "label": "TUnit", "start_offset": 45, "end_offset": 49}], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02308709", "pid": "30", "mcid": "35668", "text": "concurrent chemotherapy is allowed but not required.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02276443", "pid": "30", "mcid": "36447", "text": "patients not eligible for chemotherapy with taxane and/or anthracycline based chemotherapy regimens", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02203552", "pid": "30", "mcid": "38608", "text": "women diagnosed with breast cancer stages i-iii initiating first line adjuvant or neoadjuvant doxorubicin hydrochloride (dox) chemotherapy", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02194738", "pid": "30", "mcid": "38833", "text": "no patients who have received neoadjuvant therapy (chemo- or radio-therapy) for this lung cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02163317", "pid": "30", "mcid": "39899", "text": "previous or concurrent cytotoxic chemotherapy for prostate cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02152956", "pid": "30", "mcid": "40303", "text": "second primary malignancy that requires active therapy. adjuvant hormonal therapy is allowed.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02048371", "pid": "30", "mcid": "43309", "text": "at least one prior line of systemic therapy for the sarcoma diagnosis (neoadjuvant, adjuvant or metastatic disease)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT02027948", "pid": "30", "mcid": "43768", "text": "patients can receive chemoradiotherapy preoperatively prior to surgical resection or as definitive/primary chemoradiotherapy.", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01992861", "pid": "30", "mcid": "44509", "text": "patients who will undergo standard radiation therapy with concurrent cisplatin-based chemotherapy for cervical cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01872975", "pid": "30", "mcid": "46875", "text": "patients with histologically positive axillary nodes post neoadjuvant therapy", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01824836", "pid": "30", "mcid": "47413", "text": "patients must have completed recommended local therapy and adjuvant chemotherapy for breast cancer", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01799135", "pid": "30", "mcid": "47869", "text": "prior thoracic radiotherapy or surgery", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT01261728", "pid": "30", "mcid": "52280", "text": "prior systemic chemotherapy (prior intravesical therapy is allowed)", "entities": [], "relations": [], "Comments": []}
{"id_url": "https://classic.clinicaltrials.gov/ct2/show/NCT00715611", "pid": "30", "mcid": "53726", "text": "prior thoracic radiation therapy preventing hemithoracic pleural imrt", "entities": [], "relations": [], "Comments": []}
